Navigation Links
Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine
Date:2/8/2010

MEDFORD, Mass., Feb. 8 /PRNewswire/ -- Biocell Center announced today its further commitment to working with maternal-fetal-medicine doctors by attending the Society for Maternal-Fetal Medicine's (SMFM) annual meeting.

"Biocell Center has been working with perinatologists and Ob/Gyn doctors worldwide for several years," said Kate Torchilin, CEO of Biocell Center Corporation. "We understand the effects that high-risk pregnancy can have on mothers and families and we are hoping to inform women undergoing amniocentesis that they have a unique opportunity to cryopreserve amniotic fluid stem cells as a biological insurance for the future."

Biocell Center Corporation - the only company in the world offering the private preservation of amniotic fluid cells - attended the SMFM meeting in Chicago this week for the first time since it opened for business in the United States in late 2009.

For more information, please contact Laurie Fullerton at laurie.fullerton@biocellcenter.com or call 781-391-2040. Additionally, please go to the Biocell Center website at http://www.biocellcenter.com

This release was issued through eReleases(TM).  For more information, visit http://www.ereleases.com.

SOURCE Biocell Center Corporation

RELATED LINKS
http://www.biocellcenter.com

'/>"/>

SOURCE Biocell Center Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R)
2. UH Superconductivity Center Receives Texas Emerging Technology Fund Award
3. UMass Boston's Venture Development Center Announces New Bio-Science Partner
4. CenterWatch to Address Importance of Web Use to Boost Patient Recruitment Rates
5. Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans
6. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
7. Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
8. The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close
9. WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGens SmartChip(TM) High-throughput Real-Time PCR System
10. CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content
11. Harvest Technologies Announces Completion of Patient Enrollment in its Randomized, Controlled, Double Blind Multicenter IDE Non-Reconstructable Critical Limb Ischemia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... ... extensive coordination and expertise. Colpitts Clinical Trial Travel and Expense , a ... meeting this unique need within the biotechnology and pharmaceutical industries in the United ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... Over 8,000 ... children. In a new educational webinar on March 7, DrugDev will gather ... working in this especially difficult area. , Webinar: Overcoming the Challenges of Rare ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... high-impact life science and biotechnology companies today announced it named Joan Siefert ... be based out of Durham, NC and will begin work immediately. , Rose ...
(Date:2/28/2017)... 28, 2017 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB:REPCF) ... regenerative medicine company developing unique biologic products for pattern ... chronic tendon degeneration, today announced it has recently signed ... committed to work with RepliCel to get the Company,s ... ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
Breaking Biology News(10 mins):